Autoimmune Diseases  >>  remtolumab (ABT-122)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
remtolumab (ABT-122) / AbbVie
NCT02141997 / 2013-004019-37: A Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate

Hourglass Nov 2016 - Nov 2016 : In RA at ACR 2016
Completed
2
222
US, Europe, RoW
adalimumab, Humira, ABT-122
AbbVie
Rheumatoid Arthritis
09/15
11/15
NCT02433340 / 2014-001471-31: Phase 2, Multicenter, Open-Label Extension Study With ABT-122 in Rheumatoid Arthritis Subjects Who Have Completed the Preceding M12-963 Study

Completed
2
158
NA
ABT-122, Remtolumab
AbbVie
Rheumatoid Arthritis
05/16
05/16

Download Options